Others

Investor Relations

	'04/3	'05/3	'06/3	'07/3	'08/3	'09/3	'10/3	'11/3
Capital Expenditures (¥ Million)	51,958	85,171	80,239	60,925	38,721	51,490	30,216	40,042
Depreciation (¥ Million)	45,539	47,102	56,669	60,638	55,060	48,330	22,649	37,216
R & D Expenses (¥ Million)	31,380	32,342	33,794	33,891	33,061	40,290	38,894	37,898
Foreign Currency Exchange Gains (Losses) (¥ Million)	-5,529	332	4,466	-946	-15,159	3,156	-3,565	(7,152)
Net Financial Revenue (¥ Million)	2,370	3,318	6,283	10,414	11,808	5,791	1,478	1,385
Earnings per Share (¥)	535.62	380.22	416.39	413.57	284.66	89.76	65.10	88.07
Book Value per Share (¥)	6,026.56	6,326.64	6,821.68	7,182.64	6,895.25	6,459.81	6,439.18	6,184.91
Total Number of Employees (Number)	18,591	19,803	20,279	20,422	20,539	22,034	21,005	21,560
Number of R & D Employees (Number)	1,943	2,155	2,208	2,158	2,116	2,792	2,698	2,900
Issued Common Stock at the Term End (shares)	118,781,637	116,850,835	115,384,269	113,811,499	109,574,553	109,577,205	109,567,800	107,815,682
Averege Number of Issued Common Stock (shares)	118,783,647	118,561,981	115,768,014	114,720,030	112,168,173	109,577,205	109,569,239	109,357,216
Average Rate (¥/US$)	114.0	107.3	113.1	117.0	115.3	100.6	93.0	85.8
Dividends(¥)	55.00	85.00	90.00	100.00	230.00	130.00	130.00	130.00

≫'96/3 to '03/3

HOME, Products